Pharmaceuticals · Pharmaceuticals: Major · NSE: DCAL · data 2026-10-30

Dishman Carbogen Amcis Ltd.

₹145.02-2.94% on 30 OctHealth: Weak 3.3/10

Feb 2026Low ₹129.97 · High ₹211.88-27.8%

In plain words

Price: 52.1% below its 52-week high of ₹302.9.

Delivery: 50.6% of traded shares were kept for delivery over the last 10 sessions, against 52.2% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹145.02

Market cap

₹2,337 cr

P/E

33.3

P/B

—

ROE

1.6%

ROCE

2.6%

Debt / equity

0.46

Dividend yield

0.00%

1-year return

-50.5%

52-week high

₹302.9

52-week low

₹128.5

Operating margin

7.1%

Growth

Revenue (last 12 months)	₹2,292 cr
Net profit (last 12 months)	₹68 cr
Sales growth, 3 years (yearly)	7.6%
Profit growth, 3 years (yearly)	—

Smart-money activity

13/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 8/30: Delivery 53.7% over the last 20 sessions vs 47.8% in the 40 before (1.12x); shares delivered per day 0.51x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Dishman Carbogen Amcis Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.46.

What is Dishman Carbogen Amcis Ltd.'s P/E ratio?

About 33.3, based on the last 12 months' earnings and a price of ₹145.02 (data 2026-10-30).

What is the 52-week high and low of Dishman Carbogen Amcis Ltd.?

The 52-week high is ₹302.9 and the 52-week low is ₹128.5.

Similar companies

Hikal Limited (HIKAL) · Fredun Pharmaceuticals Ltd. (FREDUN) · Alembic Limited (ALEMBICLTD) · Sai Parenterals Limited (SAIPARENT) · Sakar Healthcare Ltd (SAKAR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open DCAL in NSE Scanner →